# of Displayed Technologies: 1 / 1

Applied Category Filter (Click To Remove): Drugs / Pharmaceuticals


New anthracycline analogues to overcome multidrug resistance
TS-015117 — Analogues therapy to overcome multi-drug resistance in cancer cells
The Need Daunorubicin is the standard anthracycline agent, a class of anti-tumor compounds used widely in the treatment of a variety of cancers. As multiple drug resistance and toxicity are serious clinical problems associated with daunorubicin, researchers have focused on improving this common …
  • College: College of Pharmacy
  • Inventors: Sun, Duxin; Fang, Lanyan; Wang, Peng George; Zhang, Guisheng
  • Licensing Officer: Flammang, Ann Marie

Loading icon